Tag: King Faisal Specialist Hospital and Research Center – KFSHRC

SAUDI ARABIA : Dr. Mahmoud Aljurf, First Non-US Physician Wins Weinberger Prize for Hematology and Stem Cell Research

Director of the Adult Stem Cell Transplantation and Cellular Therapy Program at the King Faisal Specialist Hospital & Research Centre (KFSHRC) Dr. Mahmoud Aljurf, M.D., MACP, has been awarded the Steven E. Weinberger Award for Physician Executives/Leaders by the American College of Physicians (ACP), the largest medical specialty organization in the US.


According to a recent KFSHRC press release, ‏Dr. Aljurf is the first recipient from outside the United States, underscoring his global impact on hematopoietic stem cell transplantation and oncology. He was honored at the ACP Convocation Ceremony held at the Ernest N. Morial Convention Center in New Orleans, Louisiana, during ACP’s Internal Medicine Meeting 2025.


‏At KFSHRC, Dr. Aljurf has played a key role in developing one of the world’s largest and most recognized hematopoietic stem cell transplantation programs, significantly improving treatment options for patients with hematologic malignancies. His leadership has helped expand access to novel transplant therapies and elevate global standards in hematology and oncology.


‏In addition to his clinical contributions, Dr. Aljurf is widely recognized for his research and editorial leadership. He served as the editor-in-chief of the Annals of Saudi Medicine.

He was the founding editor-in-chief of the Elsevier Journal of Hematology/Oncology and Stem Cell Therapy.

Currently, He serves as an editorial board member of several high-impact field-related scientific journals, including his role on the international advisory board of The Lancet Hematology. He has published nearly 500 scientific contributions in high-impact journals. He has also served as the editor of five books, primarily focused on building units and programs for cancer care and hematopoietic stem cell transplantation.


His contribution to bone marrow, hematopoietic stem cell transplantation, and cellular therapy was recognized by his election as the Worldwide Network for Blood and Marrow Transplantation (WBMT) president in 2023. He is the founding member and scientific director of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group, affiliated with the World Health Organization’s Eastern Mediterranean Regional Office (WHO/EMRO).


‏The release also highlighted that Dr. Aljurf was the recipient of several international awards, including the Florence A. Carter Leukemia Research Award of the American Medical Association (AMA) Education and Research Foundation, the Center for International Blood and Marrow Transplant Research (CIBMTR) Annual Distinguished Service Award, the King Hussein Cancer Foundation Lifetime Achievement Award, and the Lifetime Achievement Award from the Research Development and Innovation Authority (RDIA).

source/content: spa.gov.sa (headline edited)

______________

__________________

SAUDI ARABIA

SAUDI ARABIA: King Faisal Specialist Hospital and Research Center (KFSHRC) performs World’s First fully Robotic Heart Transplant

Saudi Arabia’s King Faisal Specialist Hospital and Research Center has performed the world’s first fully robotic heart transplant, Saudi Press Agency reported.

The two-and-a-half-hour operation was carried out on a 16-year-old patient suffering from end-stage heart failure.

A medical team led by Dr. Feras Khaliel, head of Cardiac Surgery and director of the Robotics and Minimally Invasive Surgery Program at KFSHRC, performed the operation after weeks of preparation.

The pioneering achievement, overcoming significant medical challenges associated with such procedures, reinforces Saudi Arabia’s leadership in healthcare, and highlights KFSHRC’s ability to innovate medical practices, SPA said.

The process began with detailed theoretical planning to ensure precision and minimize potential risks.

The team devised a surgical approach to access the heart and perform the transplant without opening the chest of the patient.

To ensure the effectiveness of this approach, the team practiced the procedure virtually seven times over three days before carrying out the operation.

The successful operation has been hailed as a significant development in heart transplant surgery, moving away from traditional chest-opening procedures that require long recovery periods, often lasting months.

Robotic technology allows for minimally invasive surgery, reducing pain, shortening recovery time, and minimizing the risk of complications. This significantly improves patients’ quality of life and accelerates recovery.

KFSHRC CEO Dr. Majid Al-Fayyad said that the successful operation marked another major advance in heart transplant surgery, first performed in the 1960s.

“The success of the world’s first robotic heart transplant marks a transformative leap, not only for our institution but also for Saudi Arabia’s journey toward global leadership in specialized medicine, in line with Saudi Vision 2030, which places innovation at the core of its efforts to improve quality of life,” he said.

“This remarkable achievement would not have been possible without the unwavering support of the Saudi leadership, who have prioritized the development of the healthcare sector, paving the way for a transformative leap in health care services, unlocking new possibilities to elevate the quality of life for patients both locally and globally,” he added.

The breakthrough aligns with KFSHRC’s commitment to medical innovation. As a leading training center in robotic organ transplant surgery, KFSHRC contributes to advancing the global understanding of minimally invasive organ transplants by collaborating with medical institutions worldwide to train their medical teams and achieve better outcomes, further elevating global medical practices.

source/content: arabnews.com (headline edited)

______________

Saudi hospital conducts world’s first fully robotic heart transplant. (SPA)

__________________

SAUDI ARABIA